Verve Therapeutics Overview

Life ScienceCompany

Where is Verve Therapeutics headquartered?

Verve Therapeutics is headquartered in Cambridge, Massachusetts.

What is Verve Therapeutics’ revenue?

Verve Therapeutics disclosed revenue of 32M USD for 2024 and 12M USD for 2023.

What sector is Verve Therapeutics in?

Verve Therapeutics is a life science company.

When was Verve Therapeutics founded?

Verve Therapeutics was founded in 2018.

Verve Therapeutics

Verve Therapeutics, Inc.

201 Brookline Avenue, Suite 601,
Cambridge, Massachusetts 02215
United States,
(617) 603-0070
www.vervetx.com

Verve Therapeutics is a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. Verve Therapeutics was founded in 2018 and is based in Cambridge, Massachusetts.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.